학술논문
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
Document Type
Article
Author
Source
In: BMC Gastroenterology . (BMC Gastroenterology, December 2023, 23(1))
Subject
Language
English
ISSN
1471230X